Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
6.49
-0.56 (-7.94%)
At close: Apr 28, 2026, 4:00 PM EDT
6.26
-0.24 (-3.62%)
Pre-market: Apr 29, 2026, 8:55 AM EDT
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $14.88 million as of April 29, 2026. Its market cap has increased by 627.20% in one year.
Market Cap
14.88M
Enterprise Value
7.73M
1-Year Change
627.20%
Ranking
Category
Stock Price
$6.49
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.44M to $14.88M, a decrease of -95.40%. That is a compound annual growth rate of -50.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 14.88M | 955.27% |
| Dec 31, 2025 | 1.41M | -84.90% |
| Dec 31, 2024 | 9.34M | -88.49% |
| Dec 29, 2023 | 81.16M | -75.84% |
| Dec 30, 2022 | 335.86M | 3.73% |
| Dec 31, 2021 | 323.77M | 0.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allarity Therapeutics | 21.20M |
| Quantum BioPharma | 21.09M |
| Cocrystal Pharma | 19.71M |
| Passage Bio | 18.73M |
| Lipocine | 17.67M |
| Theriva Biologics | 17.49M |
| Citius Pharmaceuticals | 17.23M |
| Pasithea Therapeutics | 17.21M |